UFP Technologies, Inc.

NASDAQ:UFPT

Medical - Devices

Healthcare
$305.65 +4.44%

+$10.10 today

Market cap
$2.37B
Beta
1.10
P/E (TTM)
26.8
EPS (TTM)
$8.89
52W Low $173.86High $274.93

Volume 0.08M

Average 0.21M

UFPT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

UFP Technologies, Inc.NASDAQ: UFPT

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 29.3%

Gross margin was 29.3% in Q2 FY2026, up 0.5 pp from a year earlier. On a trailing-twelve-month basis it was 28.5%, down 0.3 pp year over year. Over 3 fiscal years it widened by 2.8 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
29.3%+0.5 pp QoQ
Last fiscal yearDec 2025
28.3%-0.8 pp YoY
LTMJun 2026
28.5%-0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.5 pp——
1 year-0.8 pp——
3 years+2.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
28.3%
Year-over-year change
-0.8pp

Gross Margin vs competitors

How UFPT compares with its peers on the latest reported figures

  • UFPT's LTM Jun 2026 gross margin of 28.5% is the lowest of the 11 companies compared; the peer median is 61.8%.
  • Its year-over-year change of -0.3 pp is the 9th highest of 11, against a peer median of +0.8 pp.
  • Over three fiscal years its change of +2.8 pp compares with a peer median of +0.1 pp.
UFPT Competitors Peer median
Gross Margin for UFPT and competitors
Company Period LTM level YoY 3-year change
SIBNSI-BONE, Inc.LTM Mar 202679.6% +0.3 pp-5.7 pp
RXSTRxSight, Inc.LTM Mar 202677.0% +9.7 pp+33.1 pp
KIDSOrthoPediatrics Corp.LTM Mar 202673.1% +0.3 pp-1.1 pp
ESTAEstablishment Labs Holdings Inc.LTM Sep 202670.2% +1.4 pp+3.4 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
ENOVEnovis CorporationLTM Apr 202656.8% +0.3 pp+4.2 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
SSIISS Innovations International, Inc.LTM Mar 202648.4% +11.6 pp+12.4 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202642.9% +1.3 pp+0.8 pp
UFPTUFP Technologies, Inc.LTM Jun 202628.5% -0.3 pp+2.8 pp
Peer median (excluding UFPT) 61.8%+0.8 pp+0.1 pp

Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue206.32M353.79M400.07M504.42M602.8M
Cost of Revenue155.21M263.53M287.85M357.73M432.39M
Gross Profit51.11M90.26M112.23M146.69M170.41M
Gross Margin24.8%25.5%28.1%29.1%28.3%
Research & Development00000
Selling, General & Admin29.48M45.8M50.89M62.22M77.44M
Operating Expenses29.9M34.86M54.56M65.8M78.07M
Depreciation & Amortization8.41M11.89M11.41M14.72M19.15M
EBITDA29.65M67.37M68.95M95.8M111.47M
EBITDA Margin14.4%19.0%17.2%19.0%18.5%
Operating Income21.22M55.4M57.66M80.9M92.34M
Operating Margin10.3%15.7%14.4%16.0%15.3%
Interest Income49K0000
Interest Expense39K2.76M3.65M8.06M9.8M
Other Income / Expenses(13K)(2.68M)(3.76M)(7.87M)(9.83M)
Income Before Tax21.21M52.72M53.9M73.03M82.51M
Pre-Tax Margin10.3%14.9%13.5%14.5%13.7%
Income Tax Expense5.32M10.93M8.98M14.04M14.2M
Net Income15.89M41.79M44.92M58.98M68.31M
Net Margin7.7%11.8%11.2%11.7%11.3%
EPS (Basic)2.115.525.897.698.87
EPS (Diluted)2.095.455.837.588.77
Weighted Avg Shares7.52M7.56M7.62M7.67M7.71M
Weighted Avg Shares (Diluted)7.62M7.66M7.7M7.79M7.8M

UFP Technologies, Inc.

NASDAQ:UFPT

Intrinsic Alpha fair value

Locked

Current Price

$305.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.